![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
PANCREATIC DISEASES: A CLOSER LOOK
Minerva Gastroenterologica e Dietologica 2012 December;58(4):365-75
Copyright © 2012 EDIZIONI MINERVA MEDICA
language: English
Pharmacological therapy for acute pancreatitis: where are we now? where are we going?
Easler J. J., Mounzer R., Papachristou G. I. ✉
Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medi cal Center, Pittsburgh, PA, USA
Acute pancreatitis is a disease of variable severity that can lead to significant morbidity and mortality. Current management has remained limited to supportive measures and the treatment of complications. A myriad of pharmacologic therapies targeting various aspects of the underlying pathophysiology have been evaluated over the past few decades. These have included antisecretory agents, protease inhibitors, antioxidants, immunomodulators, non-steroidal anti-inflammatory medications, and prophylactic antibiotics. A few of these therapies have demonstrated promise in significantly altering the progression of this disease. Further studies are needed to clearly elucidate these benefits in patients at risk for poor outcomes